Nocturia: The Hidden Health Risk
Nocturia, or waking at night to urinate, is often overlooked but affects quality of life and health. It has defined causes, effective treatments like desmopressin, and needs greater clinical attention.
Waking at night to void is known as nocturia. It is a common condition that affects both men and women and is one of the most bothersome of lower urinary tract symptoms (LUTS). It is defined by the International. Continence Society (ICS) as ‘waking at night to void, with each void preceded and followed by sleep’. It is often perceived as a symptom of an underlying disease which, however, is not always true.
Nocturia has a profound impact on a patient’s health, quality of life, and economic condition. It is often perceived as a symptom of an organic disease, but the pathophysiology of nocturia is now well-understood, and it is considered as a disease itself. It is classified based on four different pathophysiologic mechanisms (24-hour polyuria, nocturnal polyuria, reduced bladder capacity, and sleep disorders). The association of nocturia with impaired quality of life, cardiovascular morbidity, and all-cause mortality is well established.
Various pharmacological agents are available, of which desmopressin is considered safe and effective in both short- and long-term studies for the treatment of nocturia in men and women, including the elderly. Combining desmopressin with other agents provides an effective treatment option for nocturia in patients with lower urinary tract…
Create an account to continue reading
Create AccountAlready have an account? Sign in
Need an expert in this space?
Talk to an Industry Expert
Knowledge Ridge connects decision-makers with carefully vetted subject matter experts for one-on-one calls, research sprints, and advisory engagements — across 11 sectors and 163 sub-industries globally.
Comments
No comments yet. Be the first to comment!